869. Candidalysin is a Fungal Peptide Toxin Critical for Mucosal Infection and Immune Activation
Session: Symposium: New Discoveries in an Old Field: Bacterial Toxins
Thursday, October 5, 2017: 2:50 PM
Room: 17AB
Jonathan Richardson, PhD, Mucosal & Salivary Biology, Kings College London, London, United Kingdom


Disclosures:

J. Richardson, International Patent filed on Candidalysin (Application number: PCT/GB2014/051118) , N/A

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.